Molift sold to Etac

Press release from Etac AB:

Katalysator AS and Etac AB have agreed that Etac AB acquires 100% of the shares in the company Molift Group As, Norway from date of October 19th 2010.

The transaction is to be approved by the Norwegian Competition Authority (Konkurransetilsynet).

“Molift Group AS is a well-organized company with many competent employees, a strong brand name and an innovative product line. The company suits Etac just fine, and we are looking forward to develop Molift to its next level”, says Terje Berntzen, CEO at Etac AB.

“Etac is a strong and professional player in our industry, and we in Molift are very pleased that we now can continue to develop our position together with Etac”, says Geir Olav Farstad, CEO at Molift Group AS.

“The combination of these two companies is based on industrial logic. We are very pleased with Etac as the new owner of Molift Group and we believe Etac will contribute to the future development of the company”,  says Jon Håkon Pran, CEO of Katalysator.

Etac AB manufactures and sells medical aids that improves life quality for disabled people and improves care provider working environments. It has it’s headquarter in Stockholm, sweden, and have subsidiaries in Norway, Denmark, Sweden, Germany, UK and Holland. Etac AB has a turnover of SEK 1,1 billion, and has 550 employees.

Molift Group AS develops and produces high quality products and solutions for patient transfer for the Health Care sector. Molift Group headquarter is located in Oslo, Norway. Molift Group has with its 60 employees a turnover of NOK 125 million.

Katalysator is a privately owned Norwegian investment company. Katalysator is the active owner of a number of companies in the sports and leisure, health, telecom and media sectors. Katalysator’s investment portfolio is valued at approximately NOK 600 million.